AIDDISON is Merck’s AI-powered drug discovery platform that integrates AI-powered molecule design, synthesis planning and direct sourcing of chemical building blocks to accelerate the journey ...

Merck KGaA is doubling down on AI through a new collaboration agreement with tech firm Iktos, using its generative modelling technology to speed up the discovery and design of promising new compounds.

Exscientia’s CEO, Prof Andrew Hopkins, said the Merck partnership will try to address “some of the hardest drug design challenges in cancer and immunology” while leveraging the German group ...

Merck KGaA (Merck) and Opentrons Labworks have announced a partnership to automate assay kits on a ‘custom’ Opentrons Flex ...

Kennedy Jr.'s secretary of the Department of Health and Human Services (HHS) confirmation hearing and how pharma stocks like Pfizer (PFE) and Merck (MRK) may be impacted: "There's been a lot of ...

Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and ...